- Home
- RZLT
RZLT
Rezolute Inc. (NV)
as 04-24-2025 10:42am EST
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.21 - $6.19 | Next Earning Date: | 05-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Rezolute Inc. (NV) (RZLT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hogenhuis Wladimir | RZLT | Director | Apr 1 '25 | Buy | $2.92 | 6,758 | $19,733.36 | 84,025 | |
| Elam Nevan C | RZLT | CEO | Mar 27 '25 | Buy | $2.85 | 12,302 | $34,999.19 | 224,119 | |
| Evans Daron | RZLT | CFO | Mar 26 '25 | Buy | $2.89 | 20,000 | $57,700.00 | 237,900 | |
| Hogenhuis Wladimir | RZLT | Director | Feb 16 '25 | Buy | $4.70 | 10,000 | $47,000.00 | 84,025 |
Latest Rezolute Inc. (NV) News
RZLT Breaking Stock News: Dive into RZLT Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants
GlobeNewswire
a day ago
Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”)
Simply Wall St.
2 days ago
Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans?
GlobeNewswire
a month ago
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors
GlobeNewswire
2 months ago
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
Simply Wall St.
2 months ago
Rezolute Insiders Placed Bullish Bets Worth US$557.5k
GlobeNewswire
3 months ago
Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
GlobeNewswire
3 months ago
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
Compare RZLT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RZLT Rezolute Inc. (NV) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.